Shadow Health Pharmacology Intermediate
Patient Case Exam Official Practice Exam
Actual Exam 2026/2027 with Detailed
Rationales | Complete Exam-Style Questions |
Pass Guaranteed – A+ Graded
══════════════════════════════════════
SECTION 1: COMPREHENSIVE PATIENT ASSESSMENT & MEDICATION HISTORY Q1
– Q10
══════════════════════════════════════
Question 1 of 50
A 68-year-old patient with a history of hypertension, type 2 diabetes, and chronic heart failure
presents to the clinic for a medication reconciliation visit. The patient reports taking
lisinopril 20 mg daily, metformin 1000 mg twice daily, furosemide 40 mg daily, and recently
started using over-the-counter ibuprofen 400 mg three times daily for knee pain. During the
assessment, the nurse notes the patient's blood pressure is 142/88 mmHg, heart rate is 92
bpm, and the patient reports decreased urine output over the past three days. Which clinical
priority should the nurse address first?
A. Advise the patient to increase metformin to improve glycemic control before the next A1C
check
B. Instruct the patient to discontinue ibuprofen immediately and contact the provider
regarding renal function concerns
C. Recommend the patient reduce furosemide to 20 mg daily to preserve remaining urine
output
D. Suggest the patient take lisinopril in the evening to improve the current blood pressure
reading
Correct Answer: B
Rationale: The combination of an ACE inhibitor (lisinopril), a diuretic (furosemide), and an
NSAID (ibuprofen) creates a triple whammy effect that significantly increases the risk of
acute kidney injury, and decreased urine output is an early warning sign of declining renal
function that requires immediate intervention. Discontinuing the ibuprofen removes the
nephrotoxic insult while preserving the therapeutic benefits of the ACE inhibitor and diuretic.
The Shadow Health Pharmacology Intermediate Patient Case emphasizes that medication
,reconciliation must include OTC products because they frequently contribute to adverse drug
interactions in patients with multiple comorbidities.
Question 2 of 50
A 54-year-old patient recently diagnosed with atrial fibrillation arrives for a follow-up
appointment after being started on warfarin 5 mg daily one week ago. The patient reports
eating large amounts of leafy green vegetables daily, takes a daily multivitamin, and uses St.
John's wort for mood support. The INR drawn this morning is 1.4. The nurse recognizes that
which factor is most likely contributing to the subtherapeutic anticoagulation effect?
A. The high vitamin K content in leafy green vegetables is antagonizing warfarin's
pharmacodynamic action
B. The multivitamin contains iron, which accelerates warfarin metabolism through hepatic
enzyme induction
C. St. John's wort increases warfarin absorption, leading to falsely low INR readings
D. The patient's age is causing delayed gastric emptying, reducing warfarin bioavailability
Correct Answer: A
Rationale: Warfarin exerts its anticoagulant effect by inhibiting vitamin K-dependent clotting
factors, so a diet consistently high in vitamin K from leafy greens directly antagonizes this
mechanism and lowers the INR. St. John's wort actually induces CYP450 enzymes and would
lower warfarin levels, but the primary and most predictable interaction here is the dietary
vitamin K antagonism. In the Shadow Health Pharmacology Intermediate Patient Case, nurses
are taught to assess dietary patterns as part of anticoagulation management because patient
education on vitamin K consistency is essential for safe warfarin therapy.
Question 3 of 50
During a home health visit, a nurse assesses a 72-year-old patient with Parkinson's disease
who takes carbidopa-levodopa 25/100 mg four times daily. The patient's spouse reports
increased tremor, rigidity, and episodes of freezing during movement over the past two
weeks. The patient recently started taking an over-the-counter vitamin B6 supplement 100 mg
daily for energy. Which assessment finding best explains the patient's deteriorating motor
control?
A. Vitamin B6 enhances dopamine synthesis in the substantia nigra, causing dopaminergic
overstimulation
B. Pyridoxine accelerates the peripheral decarboxylation of levodopa, reducing the amount
available to cross the blood-brain barrier
C. The vitamin B6 supplement is causing peripheral neuropathy, which mimics Parkinsonian
symptoms
D. Carbidopa inhibits vitamin B6 absorption, leading to a functional deficiency and worsening
tremor
,Correct Answer: B
Rationale: Vitamin B6 (pyridoxine) is a cofactor for the enzyme dopa decarboxylase, which
converts levodopa to dopamine in the periphery; when this conversion happens outside the
brain, less levodopa crosses the blood-brain barrier to exert its central therapeutic effect.
Carbidopa is included in the formulation specifically to inhibit peripheral decarboxylation, but
high-dose vitamin B6 can overwhelm this protective mechanism. The Shadow Health
Pharmacology Intermediate Patient Case stresses the importance of reviewing all
supplements during medication reconciliation because even seemingly benign vitamins can
have significant pharmacodynamic interactions with chronic disease medications.
Question 4 of 50
A 45-year-old patient with a history of asthma and seasonal allergies presents to the urgent
care clinic with complaints of persistent cough, wheezing, and shortness of breath for the
past five days. The patient uses an albuterol inhaler as needed and takes montelukast 10 mg
nightly. The patient recently started a new medication for depression prescribed by their
psychiatrist. On auscultation, the nurse hears diffuse wheezing and notes a respiratory rate of
24 breaths per minute. Which newly prescribed medication is most likely exacerbating this
patient's respiratory symptoms?
A. Sertraline 50 mg daily, due to its known bronchoconstrictive effects via
serotonin-mediated pathways
B. Bupropion 150 mg daily, which can cause hypersensitivity reactions including
bronchospasm in susceptible patients
C. Fluoxetine 20 mg daily, because SSRIs increase leukotriene production and worsen airway
inflammation
D. Amitriptyline 25 mg nightly, as tricyclic antidepressants directly stimulate histamine H1
receptors
Correct Answer: B
Rationale: Bupropion is associated with a higher risk of hypersensitivity reactions including
bronchospasm and should be used with caution in patients with pre-existing respiratory
conditions such as asthma. While the mechanism is not fully elucidated, case reports and
pharmacovigilance data support this association, making it the most likely culprit among the
options. The Shadow Health Pharmacology Intermediate Patient Case teaches that a
thorough medication history must include recently prescribed medications from all providers,
as drug-induced bronchospasm can mimic disease exacerbation and delay appropriate
intervention.
Question 5 of 50
A 59-year-old patient with chronic obstructive pulmonary disease (COPD) and osteoporosis is
being evaluated prior to starting a new medication regimen. The patient currently takes
tiotropium inhalation powder once daily, albuterol as needed, and calcium carbonate 600 mg
, twice daily. The provider is considering adding risedronate 35 mg weekly for bone health.
Which assessment finding would most contraindicate the initiation of risedronate in this
patient?
A. The patient's FEV1 is 58% of predicted, indicating moderate airflow limitation
B. The patient reports difficulty swallowing pills and has a history of esophageal stricture
C. The patient's calcium level is 9.2 mg/dL, which is at the lower limit of normal
D. The patient uses tiotropium, which has a known interaction with bisphosphonates
Correct Answer: B
Rationale: Bisphosphonates such as risedronate are contraindicated in patients with
esophageal abnormalities that delay esophageal emptying, including stricture, because they
can cause severe esophageal irritation, ulceration, and perforation. The medication must be
taken with a full glass of water while remaining upright for at least 30 minutes, which would
be unsafe for a patient with swallowing difficulties and esophageal pathology. The Shadow
Health Pharmacology Intermediate Patient Case highlights that medication contraindications
extend beyond drug-drug interactions to include patient-specific anatomical and physiological
barriers that increase the risk of serious adverse effects.
Question 6 of 50
A 33-year-old patient with a history of epilepsy controlled on phenytoin 300 mg daily presents
to the emergency department after a witnessed generalized tonic-clonic seizure that lasted
approximately 90 seconds. The patient reports missing two doses of phenytoin over the past
week due to running out of medication. Laboratory studies reveal a phenytoin level of 4.2
mcg/mL. The patient also mentions starting omeprazole 20 mg daily two weeks ago for
heartburn. Which factor is most likely contributing to the subtherapeutic phenytoin level and
breakthrough seizure?
A. Omeprazole inhibits CYP2C19 and CYP2C9 enzymes, which unexpectedly lowers phenytoin
metabolism
B. Omeprazole increases gastric pH, reducing phenytoin absorption and resulting in lower
serum concentrations
C. The missed doses alone explain the low level, and omeprazole has no clinically significant
interaction with phenytoin
D. Phenytoin induces omeprazole metabolism, causing rebound acid hypersecretion and
altered phenytoin binding
Correct Answer: B
Rationale: Phenytoin absorption is highly dependent on gastric acidity, and omeprazole raises
gastric pH through proton pump inhibition, which can significantly reduce the dissolution and
absorption of phenytoin and lead to subtherapeutic levels. While missed doses certainly
contributed, the addition of omeprazole represents a modifiable pharmacokinetic interaction
that the nurse must recognize and address with the provider. The Shadow Health
Patient Case Exam Official Practice Exam
Actual Exam 2026/2027 with Detailed
Rationales | Complete Exam-Style Questions |
Pass Guaranteed – A+ Graded
══════════════════════════════════════
SECTION 1: COMPREHENSIVE PATIENT ASSESSMENT & MEDICATION HISTORY Q1
– Q10
══════════════════════════════════════
Question 1 of 50
A 68-year-old patient with a history of hypertension, type 2 diabetes, and chronic heart failure
presents to the clinic for a medication reconciliation visit. The patient reports taking
lisinopril 20 mg daily, metformin 1000 mg twice daily, furosemide 40 mg daily, and recently
started using over-the-counter ibuprofen 400 mg three times daily for knee pain. During the
assessment, the nurse notes the patient's blood pressure is 142/88 mmHg, heart rate is 92
bpm, and the patient reports decreased urine output over the past three days. Which clinical
priority should the nurse address first?
A. Advise the patient to increase metformin to improve glycemic control before the next A1C
check
B. Instruct the patient to discontinue ibuprofen immediately and contact the provider
regarding renal function concerns
C. Recommend the patient reduce furosemide to 20 mg daily to preserve remaining urine
output
D. Suggest the patient take lisinopril in the evening to improve the current blood pressure
reading
Correct Answer: B
Rationale: The combination of an ACE inhibitor (lisinopril), a diuretic (furosemide), and an
NSAID (ibuprofen) creates a triple whammy effect that significantly increases the risk of
acute kidney injury, and decreased urine output is an early warning sign of declining renal
function that requires immediate intervention. Discontinuing the ibuprofen removes the
nephrotoxic insult while preserving the therapeutic benefits of the ACE inhibitor and diuretic.
The Shadow Health Pharmacology Intermediate Patient Case emphasizes that medication
,reconciliation must include OTC products because they frequently contribute to adverse drug
interactions in patients with multiple comorbidities.
Question 2 of 50
A 54-year-old patient recently diagnosed with atrial fibrillation arrives for a follow-up
appointment after being started on warfarin 5 mg daily one week ago. The patient reports
eating large amounts of leafy green vegetables daily, takes a daily multivitamin, and uses St.
John's wort for mood support. The INR drawn this morning is 1.4. The nurse recognizes that
which factor is most likely contributing to the subtherapeutic anticoagulation effect?
A. The high vitamin K content in leafy green vegetables is antagonizing warfarin's
pharmacodynamic action
B. The multivitamin contains iron, which accelerates warfarin metabolism through hepatic
enzyme induction
C. St. John's wort increases warfarin absorption, leading to falsely low INR readings
D. The patient's age is causing delayed gastric emptying, reducing warfarin bioavailability
Correct Answer: A
Rationale: Warfarin exerts its anticoagulant effect by inhibiting vitamin K-dependent clotting
factors, so a diet consistently high in vitamin K from leafy greens directly antagonizes this
mechanism and lowers the INR. St. John's wort actually induces CYP450 enzymes and would
lower warfarin levels, but the primary and most predictable interaction here is the dietary
vitamin K antagonism. In the Shadow Health Pharmacology Intermediate Patient Case, nurses
are taught to assess dietary patterns as part of anticoagulation management because patient
education on vitamin K consistency is essential for safe warfarin therapy.
Question 3 of 50
During a home health visit, a nurse assesses a 72-year-old patient with Parkinson's disease
who takes carbidopa-levodopa 25/100 mg four times daily. The patient's spouse reports
increased tremor, rigidity, and episodes of freezing during movement over the past two
weeks. The patient recently started taking an over-the-counter vitamin B6 supplement 100 mg
daily for energy. Which assessment finding best explains the patient's deteriorating motor
control?
A. Vitamin B6 enhances dopamine synthesis in the substantia nigra, causing dopaminergic
overstimulation
B. Pyridoxine accelerates the peripheral decarboxylation of levodopa, reducing the amount
available to cross the blood-brain barrier
C. The vitamin B6 supplement is causing peripheral neuropathy, which mimics Parkinsonian
symptoms
D. Carbidopa inhibits vitamin B6 absorption, leading to a functional deficiency and worsening
tremor
,Correct Answer: B
Rationale: Vitamin B6 (pyridoxine) is a cofactor for the enzyme dopa decarboxylase, which
converts levodopa to dopamine in the periphery; when this conversion happens outside the
brain, less levodopa crosses the blood-brain barrier to exert its central therapeutic effect.
Carbidopa is included in the formulation specifically to inhibit peripheral decarboxylation, but
high-dose vitamin B6 can overwhelm this protective mechanism. The Shadow Health
Pharmacology Intermediate Patient Case stresses the importance of reviewing all
supplements during medication reconciliation because even seemingly benign vitamins can
have significant pharmacodynamic interactions with chronic disease medications.
Question 4 of 50
A 45-year-old patient with a history of asthma and seasonal allergies presents to the urgent
care clinic with complaints of persistent cough, wheezing, and shortness of breath for the
past five days. The patient uses an albuterol inhaler as needed and takes montelukast 10 mg
nightly. The patient recently started a new medication for depression prescribed by their
psychiatrist. On auscultation, the nurse hears diffuse wheezing and notes a respiratory rate of
24 breaths per minute. Which newly prescribed medication is most likely exacerbating this
patient's respiratory symptoms?
A. Sertraline 50 mg daily, due to its known bronchoconstrictive effects via
serotonin-mediated pathways
B. Bupropion 150 mg daily, which can cause hypersensitivity reactions including
bronchospasm in susceptible patients
C. Fluoxetine 20 mg daily, because SSRIs increase leukotriene production and worsen airway
inflammation
D. Amitriptyline 25 mg nightly, as tricyclic antidepressants directly stimulate histamine H1
receptors
Correct Answer: B
Rationale: Bupropion is associated with a higher risk of hypersensitivity reactions including
bronchospasm and should be used with caution in patients with pre-existing respiratory
conditions such as asthma. While the mechanism is not fully elucidated, case reports and
pharmacovigilance data support this association, making it the most likely culprit among the
options. The Shadow Health Pharmacology Intermediate Patient Case teaches that a
thorough medication history must include recently prescribed medications from all providers,
as drug-induced bronchospasm can mimic disease exacerbation and delay appropriate
intervention.
Question 5 of 50
A 59-year-old patient with chronic obstructive pulmonary disease (COPD) and osteoporosis is
being evaluated prior to starting a new medication regimen. The patient currently takes
tiotropium inhalation powder once daily, albuterol as needed, and calcium carbonate 600 mg
, twice daily. The provider is considering adding risedronate 35 mg weekly for bone health.
Which assessment finding would most contraindicate the initiation of risedronate in this
patient?
A. The patient's FEV1 is 58% of predicted, indicating moderate airflow limitation
B. The patient reports difficulty swallowing pills and has a history of esophageal stricture
C. The patient's calcium level is 9.2 mg/dL, which is at the lower limit of normal
D. The patient uses tiotropium, which has a known interaction with bisphosphonates
Correct Answer: B
Rationale: Bisphosphonates such as risedronate are contraindicated in patients with
esophageal abnormalities that delay esophageal emptying, including stricture, because they
can cause severe esophageal irritation, ulceration, and perforation. The medication must be
taken with a full glass of water while remaining upright for at least 30 minutes, which would
be unsafe for a patient with swallowing difficulties and esophageal pathology. The Shadow
Health Pharmacology Intermediate Patient Case highlights that medication contraindications
extend beyond drug-drug interactions to include patient-specific anatomical and physiological
barriers that increase the risk of serious adverse effects.
Question 6 of 50
A 33-year-old patient with a history of epilepsy controlled on phenytoin 300 mg daily presents
to the emergency department after a witnessed generalized tonic-clonic seizure that lasted
approximately 90 seconds. The patient reports missing two doses of phenytoin over the past
week due to running out of medication. Laboratory studies reveal a phenytoin level of 4.2
mcg/mL. The patient also mentions starting omeprazole 20 mg daily two weeks ago for
heartburn. Which factor is most likely contributing to the subtherapeutic phenytoin level and
breakthrough seizure?
A. Omeprazole inhibits CYP2C19 and CYP2C9 enzymes, which unexpectedly lowers phenytoin
metabolism
B. Omeprazole increases gastric pH, reducing phenytoin absorption and resulting in lower
serum concentrations
C. The missed doses alone explain the low level, and omeprazole has no clinically significant
interaction with phenytoin
D. Phenytoin induces omeprazole metabolism, causing rebound acid hypersecretion and
altered phenytoin binding
Correct Answer: B
Rationale: Phenytoin absorption is highly dependent on gastric acidity, and omeprazole raises
gastric pH through proton pump inhibition, which can significantly reduce the dissolution and
absorption of phenytoin and lead to subtherapeutic levels. While missed doses certainly
contributed, the addition of omeprazole represents a modifiable pharmacokinetic interaction
that the nurse must recognize and address with the provider. The Shadow Health
